Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

References

• GoASBaumanMAColeman KingSMAn effective approach to high blood pressure control: A science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and PreventionJ Am Coll Cardiol201463121230123824246165
   PubMed Web of Science ®Google Scholar
• KostisJBCabreraJChengJQAssociation between chlorthalidone treatment of systolic hypertension and long-term survivalJAMA2011306232588259322187278
   PubMed Web of Science ®Google Scholar
• McalisterFAWilkinsKJoffresMChanges in the rates of awareness, treatment and control of hypertension in Canada over the past two decadesCMAJ201118391007101321576297
   PubMed Web of Science ®Google Scholar
• TuKCampbellNRCDuong-HuaMMcalisterFAHypertension management in the elderly has improved - Ontario prescribing trends, 1994–2002Hypertension2005451113111815851629
   PubMed Web of Science ®Google Scholar
• OliverasAArmarioPLucasSde La SierraACOMBICONTROL Study InvestigatorsBlood pressure control is similar in treated hypertensive patients with optimal or with high-normal albuminuriaAm J Hypertens20142791185119024646879
   PubMed Web of Science ®Google Scholar
• Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of HypertensionJ Clin Hypertens2014161426
   PubMed Web of Science ®Google Scholar
• SPRINT Research GroupWrightJTWilliamsonJDA randomized trial of intensive versus standard blood-pressure controlN Engl J Med2015373222103211626551272
   PubMed Web of Science ®Google Scholar
• ACCORD Study GroupCushmanWCEvansGWEffects of intensive blood-pressure control in type 2 diabetes mellitusN Engl J Med2010362171575158520228401
   PubMed Web of Science ®Google Scholar
• BurgessEEplerenone in hypertensionExpert Opin Pharmacother20045122573258115571474
   PubMed Web of Science ®Google Scholar
• JansenPMFrenkelWJvan den BornBJDeterminants of blood pressure reduction by eplerenone in uncontrolled hypertensionJ Hypertens201331240441323249826
   PubMed Web of Science ®Google Scholar
• KarnsADBralJMHartmanDPeppardTSchumacherCStudy of aldosterone synthase inhibition as an add-on therapy in resistant hypertensionJ Clin Hypertens2013153186192
   PubMed Web of Science ®Google Scholar
• WilliamsBMacdonaldTMMorantSSpironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialLancet2015386100082059206826414968
   PubMed Web of Science ®Google Scholar
• BombackASKlemmerPJThe incidence and implications of aldosterone breakthroughNat Clin Pract Nephrol20073948649217717561
   PubMedGoogle Scholar
• ZannadFMcMurrayJJKrumHEplerenone in patients with systolic heart failure and mild symptomsN Engl J Med20113641112121073363
   PubMed Web of Science ®Google Scholar
• PittBZannadFRemmeWJThe effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsN Engl J Med19993411070971710471456
   PubMed Web of Science ®Google Scholar
• PittBRemmeWZannadFEplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarctionN Engl J Med2003348141309132112668699
   PubMed Web of Science ®Google Scholar
• BatterinkJStablerSNTejaniAMFowkesCTSpironolactone for hypertensionCochrane Database Syst Rev20108CD00816920687095
   PubMed Web of Science ®Google Scholar
• CroomKFPerryCMEplerenone: a review of its use in essential hypertensionAm J Cardiovasc Drugs200551516915631538
   PubMedGoogle Scholar
• Rafestin-OblinMERudolphAFaggartJEplerenone: a selective aldosterone blockerJ Hypertens200321Suppl 4202
   Google Scholar
• de GasparoMJossURamjouéHPThree new epoxy-spirolactone derivatives: characterization in vivo and in vitroJ Pharmacol Exp Ther198724026506562949071
   PubMed Web of Science ®Google Scholar
• GarthwaiteSMMcMahonEGThe evolution of aldosterone antagonistsMol Cell Endocrinol20042171–2273115134797
   PubMed Web of Science ®Google Scholar
• Pfizer Canada IncINSPRA Product Monograph2014
   Google Scholar
• YamajiMTsutamotoTKawaharaCNishiyamaKYamamotoTFujiiMHorieMEffect of eplerenone versus spironolactone on cortisol and hemoglobin A1(c) levels in patients with chronic heart failureAm Heart J2010160591592121095280
   PubMed Web of Science ®Google Scholar
• LainscakMPellicciaFRosanoGSafety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenoneInt J Cardiol2015200252926404748
   PubMed Web of Science ®Google Scholar
• JankowskaEABielBMajdaJAnabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survivalCirculation20061141829183717030678
   PubMed Web of Science ®Google Scholar
• Pfizer IncINSPRA US Package Insert2016
   Google Scholar
• PellicciaFPattiGRosanoGGrecoCGaudioCEfficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysisInt J Cardiol2014177121922825499383
   PubMed Web of Science ®Google Scholar
• TamTSWuMHMassonSCEplerenone for hypertensionCochrane Database Syst Rev20172CD00899628245343
   PubMedGoogle Scholar
• PrestonRAMatersonBJRedaDJWilliamsDWPlacebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative StudyArch Intern Med2000160101449145410826457
   PubMedGoogle Scholar
• GuQBurtVLDillonCFYoonSTrends in antihypertensive medication use and blood pressure control among United States adults with hypertension. The National Health and Nutrition Evaluation Survey, 2001–2010Circulation2012126172105211423091084
   PubMed Web of Science ®Google Scholar
• WeinbergerMHEplerenone, a selective aldosterone blocker, in mild-to-moderate hypertensionAm J Hypertens20021570971612160194
   PubMed Web of Science ®Google Scholar